- Filed
- Sep 27, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q2 2024 · Jun 30, 2024 | $1.81M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $2.55M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $2.89M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $3.32M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $7.55M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $6.47M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $7.55M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $6.47M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $38.4M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $39.52M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $47.24M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $48.83M |
| Sga Expense | Q2 2024 · Jun 30, 2024 | $1.96M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $1.05M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 1.53M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $7.19K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $2.64M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $43.29M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $45.44M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Net Income | Q2 2024 · Jun 30, 2023 | −$4.08K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$636.81K |
| Gross Profit restated | Q2 2024 · Jun 30, 2023 | −$185.81K |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $294.6K |
| Revenue restated | Q2 2024 · Jun 30, 2023 | $108.78K |